[EN] ISOQUINOLINES AS INHIBITORS OF HPK1<br/>[FR] ISOQUINOLÉINES UTILISÉES EN TANT QU'INHIBITEURS DE HPK1
申请人:GENENTECH INC
公开号:WO2018183964A1
公开(公告)日:2018-10-04
Isoquinoline compounds and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The compounds are useful in treating HPK1 -dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1 -dependent disorders, methods for enhancing an immune response, and methods for preparing the isoquinoline compounds.